Pathological complete response rates following different neoadjuvant chemotherapy regimens for Operable Breast Cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)

Milvia Zambetti, Mauro Mansutti, Patricia Gomez, Ana Lluch, Christian Dittrich, Claudio Zamagni, Eva Ciruelos, Lorenzo Pavesi, Vladimir Semiglazov, Elena De Benedictis, Fernando Gaion, Mario Bari, Paolo Morandi, Pinuccia Valagussa, Gianni Luca

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pathological complete response rates following different neoadjuvant chemotherapy regimens for Operable Breast Cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)'. Together they form a unique fingerprint.

Medicine & Life Sciences